Sudarshan Pharma Industries Limited (BOM:543828)
31.00
+0.01 (0.03%)
At close: May 5, 2026
BOM:543828 Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 11.35 | 5.51 | 1.44 | 117.19 | 2.36 |
Short-Term Investments | - | 15 | 15 | - | - |
Cash & Short-Term Investments | 11.35 | 20.51 | 16.44 | 117.19 | 2.36 |
Cash Growth | -44.66% | 24.76% | -85.97% | 4865.47% | -81.19% |
Accounts Receivable | 2,333 | 1,602 | 1,225 | 815.09 | 734.77 |
Other Receivables | - | 9.42 | 77.16 | 6.1 | 2.69 |
Receivables | 2,333 | 1,657 | 1,303 | 929.89 | 737.46 |
Inventory | 2,187 | 1,405 | 857.41 | 745.68 | 468.7 |
Prepaid Expenses | - | 20.31 | 17.84 | 4.76 | 1.82 |
Other Current Assets | 370.5 | 245.71 | 177.89 | 188.71 | 85.46 |
Total Current Assets | 4,903 | 3,348 | 2,372 | 1,986 | 1,296 |
Property, Plant & Equipment | 808.48 | 260.91 | 224.1 | 190.03 | 68.84 |
Long-Term Investments | 0.02 | 288.4 | 123.41 | 123.41 | 0.02 |
Goodwill | 52.2 | 34.88 | 43.59 | - | - |
Other Intangible Assets | 99.68 | 3.31 | 6.15 | 8.97 | 1.19 |
Other Long-Term Assets | 554.47 | 77.32 | 51.18 | 5.85 | 0.49 |
Total Assets | 6,417 | 4,024 | 2,831 | 2,325 | 1,375 |
Accounts Payable | 1,877 | 918.33 | 567.15 | 918.89 | 737.51 |
Accrued Expenses | 0.19 | 8.66 | 44.29 | 29.1 | 24.25 |
Short-Term Debt | 2,551 | 1,566 | 905.59 | 183.52 | 235.92 |
Current Portion of Long-Term Debt | - | 36.85 | 37.87 | 29.63 | 20.6 |
Current Portion of Leases | 13.08 | - | - | - | - |
Current Income Taxes Payable | 71.63 | 51.75 | 24.36 | 6.4 | 3.26 |
Other Current Liabilities | 48.04 | 15.49 | 25.65 | 17.22 | 4.7 |
Total Current Liabilities | 4,561 | 2,597 | 1,605 | 1,185 | 1,026 |
Long-Term Debt | 283.69 | 104.6 | 104.91 | 127.88 | 49.4 |
Long-Term Leases | 2.59 | - | - | - | - |
Pension & Post-Retirement Benefits | - | 1.34 | 0.7 | 0.5 | 0.31 |
Long-Term Deferred Tax Liabilities | 1.51 | 2.86 | 0.18 | 1.8 | 1.41 |
Other Long-Term Liabilities | 5.34 | 3.54 | 3.48 | 0.09 | 0.11 |
Total Liabilities | 4,854 | 2,709 | 1,714 | 1,315 | 1,077 |
Common Stock | 240.66 | 240.66 | 240.66 | 240.66 | 97.49 |
Additional Paid-In Capital | - | 578.08 | 578.1 | 578.1 | 79.66 |
Retained Earnings | - | 457.86 | 298.31 | 190.97 | 120.61 |
Comprehensive Income & Other | 1,310 | 38.21 | - | - | - |
Total Common Equity | 1,551 | 1,315 | 1,117 | 1,010 | 297.75 |
Minority Interest | 12.21 | 0.01 | - | - | - |
Shareholders' Equity | 1,563 | 1,315 | 1,117 | 1,010 | 297.75 |
Total Liabilities & Equity | 6,417 | 4,024 | 2,831 | 2,325 | 1,375 |
Total Debt | 2,850 | 1,707 | 1,048 | 341.04 | 305.92 |
Net Cash (Debt) | -2,839 | -1,687 | -1,032 | -223.85 | -303.56 |
Net Cash Per Share | -11.82 | -6.98 | -4.32 | -0.93 | -2.11 |
Filing Date Shares Outstanding | 223.46 | 240.66 | 240.66 | 240.66 | 166.78 |
Total Common Shares Outstanding | 223.46 | 240.66 | 240.66 | 240.66 | 146.23 |
Working Capital | 341.46 | 751.53 | 767.29 | 801.45 | 269.55 |
Book Value Per Share | 6.94 | 5.46 | 4.64 | 4.20 | 2.04 |
Tangible Book Value | 1,399 | 1,277 | 1,067 | 1,001 | 296.56 |
Tangible Book Value Per Share | 6.26 | 5.30 | 4.44 | 4.16 | 2.03 |
Land | - | 104.73 | 104.73 | 104.73 | 3.21 |
Buildings | - | 15.3 | 15.3 | 14.77 | 14.77 |
Machinery | - | 122.53 | 116.67 | 92.14 | 62.9 |
Construction In Progress | - | 60.41 | 18.8 | 0.12 | 5.36 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.